High density lipoprotein influences CD4 T cell proliferation in Systemic Lupus Erythematosus and increases TGF-β1 expression: A potential role in the protection from atherosclerosis and autoimmunity
Restricted accessLetterFirst published online October, 2021
High density lipoprotein influences CD4 T cell proliferation in Systemic Lupus Erythematosus and increases TGF-β1 expression: A potential role in the protection from atherosclerosis and autoimmunity
Romo-TenaJKaplanMJ.Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update. Curr Opin Rheumatol2020; 32: 562–571.
2.
BruceIN. ‘Not only … but also ’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford)2005; 44: 1492–1502.
3.
SurlsJNazarov-StoicaCKehlMOlsenCCasaresSBrumeanuTD.Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response. PLoS One2012; 7: 1–13.
4.
FengHGuoLWangD, et al. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol2011; 31: 2543–2551.
5.
LarbiAFortinCDupuisGBerrouguiHKhalilAFulopT.Immunomodulatory role of high-density lipoproteins: impact on immunosenescence. Age (Omaha)2014; 36: 9712.
6.
InoueMNikiMOzekiY, et al. High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages. Sci Rep2018; 8: 1–11.
7.
FotakisPKothariVThomasDG, et al. Anti-inflammatory effects of HDL (high-density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques. Arterioscler Thromb Vasc Biol2019; 39: e253–e272.
8.
ZhouBXiaYSheJ.Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study. Lipids Health Dis2020; 19: 40–46.
9.
Norata GD, Callegari E, Marchesi M, Chiesa G, Eriksson P, Catapano AL. High-density lipoproteins induce transforming growth factor- β2 expression in endothelial cells. Circulation 2005; 111: 2805--2811.
10.
Metawie SA, ElRefai RM, ElAdle SS, Shahin RMH. Transforming growth factor-?1 in systemic lupus erythematosus patients and its relation to organ damage and disease activity. Egypt Rheumatol 2015; 37: S49--54.
11.
Rekik R, Smiti Khanfir M, Larbi T, Zamali I, Beldi-Ferchiou A, Kammoun O, et al. Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22. Cytokine 2018; 108: 182--189.
12.
Jackson M, Ahmad Y, Bruce IN, Coupes B, Brenchley PEC. Activation of transforming growth factor- β 1 and early atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2006; 7: 1--7.
